Abstract
We focus on the role of Vpr in inducing DNA double-strand breaks (DSBs) in the host cell. Based on the summarized findings of Vpr-induced DSBs and the finding of Vpr in the plasma of HIV-1-positive patients, we discuss the roles of Vpr in viral infection, especially viral infection of resting macrophages. We also describe the possible involvement of Vpr in non-AIDS-defining cancers, which represent an emerging crisis in HIV-1-positive patients.
Keywords: HIV-1, Vpr, DNA double-strand breaks, ATM, homologous recombination, non-AIDS-defining cancers
Current HIV Research
Title: Vpr-Induced DNA Double-Strand Breaks: Molecular Mechanism and Biological Relevance
Volume: 7 Issue: 2
Author(s): Chikako Nakai-Murakami, Yuzuru Minemoto and Yukihito Ishizaka
Affiliation:
Keywords: HIV-1, Vpr, DNA double-strand breaks, ATM, homologous recombination, non-AIDS-defining cancers
Abstract: We focus on the role of Vpr in inducing DNA double-strand breaks (DSBs) in the host cell. Based on the summarized findings of Vpr-induced DSBs and the finding of Vpr in the plasma of HIV-1-positive patients, we discuss the roles of Vpr in viral infection, especially viral infection of resting macrophages. We also describe the possible involvement of Vpr in non-AIDS-defining cancers, which represent an emerging crisis in HIV-1-positive patients.
Export Options
About this article
Cite this article as:
Nakai-Murakami Chikako, Minemoto Yuzuru and Ishizaka Yukihito, Vpr-Induced DNA Double-Strand Breaks: Molecular Mechanism and Biological Relevance, Current HIV Research 2009; 7 (2) . https://dx.doi.org/10.2174/157016209787581391
DOI https://dx.doi.org/10.2174/157016209787581391 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV Vaccine Development.
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
Lymphomas in People Living with HIV (PLWH)
In the era of combined antiretroviral therapy (cART), the incidence of lymphoma among people living with HIV (PLWH) surpassed Kaposi's sarcoma in 2011, becoming the most common AIDS-defining malignancy. The annual incidence rate ranges approximately from 100 to 300 per 100,000 individuals with HIV infection as the population denominator, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aptamer-Based Strategies for Stem Cell Research
Mini-Reviews in Medicinal Chemistry The Therapeutic Potential of Targeting the Toll-like Receptor Pathway in Breast Cancer
Current Pharmaceutical Design Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research Recent Patents and Patent Applications Relating to mTOR Pathway
Recent Patents on DNA & Gene Sequences The Role of Glycoprotein H in Herpesvirus Membrane Fusion
Protein & Peptide Letters Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects
Current Pharmaceutical Design Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design In Silico Design of Protein Kinase Inhibitors: Successes and Failures
Anti-Cancer Agents in Medicinal Chemistry Activation of Transient Receptor Potential Vanilloid (TRPV) 4 as a Therapeutic Strategy in Osteoarthritis
Current Topics in Medicinal Chemistry Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
Current Drug Discovery Technologies Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Current Pharmaceutical Biotechnology Preclinical Evaluation of New Taxoids
Current Pharmaceutical Design Targeting Angiogenesis in Renal Cell Carcinoma
Current Cancer Drug Targets Stem Cell Guardians – Old and New Perspectives in LSC Biology
Current Drug Targets Changes of Gene Expression in the Developing Brain by Acute Ethanol Exposure
Current Psychopharmacology Quinoxalinone as a Privileged Platform in Drug Development
Mini-Reviews in Medicinal Chemistry Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology